HemAQuest.com

About HemAQuest.com

HemaQuest is a Seattle-based biopharmaceutical company developing proprietary small molecules targeting specific genes that enable the treatment of serious and life threatening hematologic disorders. Currently, the Company has two therapeutics in Phase 2 clinical development - HQK-1001 for hemoglobin disorders, such as sickle cell disease, and HQK-1004 for viral-related cancers.



Retrieved from "http://aboutus.com/index.php?title=HemAQuest.com&oldid=35903192"